Moreover, previous studies of our lab using in vivo models of carcinogen-induced colon cancer [11, 12] demonstrated a tumor-promoting role of NF-κB signaling in myeloid cells during tumor promotion and progression. This evidence concerns the gene NFKB1 and neoplasm.